|
|
The Opportunity for Profiling Diagnostics to Accelerate the Adoption of Personalized HealthPublished by: IDC Published: Dec. 27, 2006 - 15 Pages Table of ContentsTable of Contents Health Industry Insights Opinion In This Report Situation Overview The State of the Health Industry Today The Move Toward Personalized Health Current Industry Dynamics The Drug Development Industry Healthcare Providers Healthcare Payers The Need for a Better Approach ? Profiling Diagnostics The Vision for Profiling Diagnostics How Does Profiling Diagnostics Differ from Current Practices? Market Models Enabling Emerging Diagnostic Solutions Emerging Profiling Diagnostics Market Solutions Profiling Diagnostic Companies Technology Platforms Supporting Profiling Diagnostics Development Table: Selected Profiling Diagnostic Companies, Products, and Tests Table: Selected Commercial Diagnostic Technology Platforms Direct-to-Consumer Profiling Diagnostic Testing Table: Selected Direct-to-Consumer Commercial Test Offerings Contract Pharmacogenomics Testing The Regulatory Wildcard ? Proposed Regulation of Multianalyte Diagnostics Future Outlook Essential Guidance Actions to Consider Learn More Related Research Synopsis AbstractThis Health Industry Insights report examines the emerging opportunity for profiling diagnostics to transform healthcare delivery through the incorporation of growing detailed understanding of normal biological and disease processes into clinical decision making. The report highlights current industry practices, the vision for a profiling diagnostics solution, leading emerging product offerings and commercial enablers, and key drivers and barriers to success. This and future reports provide actionable strategic insights that drug development companies, supporting industries, healthcare providers, and healthcare payers should consider in the transformation of the life science and healthcare industries toward personalized health. "Biological knowledge is becoming an integral part of the health industry, and profiling diagnostics will be a leading contributor to improving the delivery of healthcare at the level of the individual. Efficient transformation of biological knowledge into actionable clinical decision support is an important first step," said Alan Louie, Ph.D., research director for Health Industry Insights. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||